HOME >> MEDICINE >> NEWS
Even in an era of HAART Drugs, HIV patients are vulnerable to opportunistic infections

line therapy. They may not be effective, however, in patients who have previously had treatment with this class of drugs. Patients who are responding to HAART may be doing well enough that they don't need prophylaxis, she said.

"The risks versus benefits must be carefully evaluated. We want to protect patients from MAC, but we also want to prevent them from developing resistance to antibiotics," said Aberg, who is a UCSF assistant professor of medicine and also treats patients at San Francisco General.

In the pre-HAART era, macrolides were standard treatment as prevention therapy against MAC infection in AIDS patients whose CD4+ counts were below 75, according to Aberg. Now with HAART, many patients may have CD4+ counts that are higher.

The main conclusion from study findings, she said, is that careful consideration should be given to continuing use of macrolides for MAC prophylaxis when CD4+ counts have increased and to using macrolides for infection treatment if a patient has been on a macrolide previously.

Both research studies were supported by grants from the NIH UCSF Center for AIDS Research and the UC Universitywide AIDS Research Program,

In addition, the CMV retinitis study received a grant from Research to Prevent Blindness, Inc., and the macrolide bacterial resistance study received support from Abbott Laboratories.


'"/>

Contact: Corinna Kaarlela
ckaarlela@pubaff.ucsf.edu
415-476-3804
University of California - San Francisco
27-Sep-1999


Page: 1 2 3

Related medicine news :

1. Most episodes of HIV blips not clinically significant in patients receiving HAART
2. Multiple characteristics of HAART affect adherence
3. Researchers examine the use of antiretroviral therapy among injection drug users with HIV infection: Study suggests addiction treatment and health care contribute to HAART enrollment
4. ICAAC highlight: MAC prophylaxis can be safely discontinued in HIV-infected patients who respond to HAART
5. Old Drugs, New Tricks
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. Study finds that coordinating care of chronically ill patients does not increase liability
8. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
9. Optical technique identifies vulnerable plaques in cardiac patients
10. NHS target driven culture is failing patients
11. Cardiac deaths peak in sleep hours for patients with sleep apnea

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/13/2017)... Boulder, CO (PRWEB) , ... January 13, 2017 , ... ... Congress, a growing alliance of deans of colleges and schools of education across the ... public schools. , In a Declaration of Principles released today, 175 deans sounded the ...
(Date:1/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a new ... way to peace, health and eternal joy. Yisrayl says he has been accused of being ... that false accusations and persecution are nothing new in his world and says it has ...
(Date:1/13/2017)... , ... January 13, 2017 , ... One way to ... nationals can qualify if they can show their work is in the national interest. ... self-petition rather than having to be sponsored by an employer; and 2) the submission ...
(Date:1/13/2017)... ... 13, 2017 , ... U.S. News & World Report highly ... its 2017 Best Online Graduate Nursing Programs list released Jan. 10. The School ... graduate degree programs include a family nurse practitioner doctor of nursing practice (DNP), ...
(Date:1/13/2017)... ... 2017 , ... PrideStaff, a national, franchised staffing organization ... franchise by Entrepreneur. , The 38th annual Franchise 500® ranking was determined using ... success. All entrants were judged by financial strength and stability, growth rate and ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Jan 13, 2017 Research and Markets has ... and Analysis" report to their offering. ... Cystic fibrosis (CF) is a progressive ... faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. ... epithelial cells, and result in the buildup of a thick and ...
(Date:1/13/2017)... -- ... Research and Markets has announced the addition of the ... offering. The disease is divided into two categories ... melanoma, which can be treated with surgery, and advanced melanoma, which ... therapy aiming to prevent disease re-occurrence, and advanced therapies aiming to ...
(Date:1/12/2017)... Imaging, Inc., leading designer and manufacturer of the innovative ... proud to announce FDA 510(k) clearance of the G-Arm ... of the G-Arm with major improvements including axial tilt ... be launching this sooner than our original intended date," ... Marketing at Whale. "We feel that getting the B6 ...
Breaking Medicine Technology:
Cached News: